Unbiased AI-powered news
1 stories related to this topic, newest first.
foxbusiness.comThe Food and Drug Administration turned down an experimental melanoma treatment on two separate occasions after raising questions about how the supporting clinical study was structured. The agency cited concerns with the trial's design as the basis for both rejections.